MX2008013777A - Usos medicos adicionales de la proteina antisecretora. - Google Patents
Usos medicos adicionales de la proteina antisecretora.Info
- Publication number
- MX2008013777A MX2008013777A MX2008013777A MX2008013777A MX2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A MX 2008013777 A MX2008013777 A MX 2008013777A
- Authority
- MX
- Mexico
- Prior art keywords
- caveolae
- dysfunction
- lipid rafts
- antisecretory protein
- receptors
- Prior art date
Links
- 230000001262 anti-secretory effect Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 210000004323 caveolae Anatomy 0.000 abstract 3
- 230000004064 dysfunction Effects 0.000 abstract 3
- 150000002632 lipids Chemical class 0.000 abstract 3
- 230000002265 prevention Effects 0.000 abstract 2
- 208000017701 Endocrine disease Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000007488 abnormal function Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000005980 lung dysfunction Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000006492 vascular dysfunction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0600933 | 2006-04-27 | ||
| US92082607P | 2007-03-30 | 2007-03-30 | |
| PCT/SE2007/000415 WO2007126365A2 (en) | 2006-04-27 | 2007-04-27 | Further medical uses of antisecretory protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008013777A true MX2008013777A (es) | 2009-02-03 |
Family
ID=38655930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008013777A MX2008013777A (es) | 2006-04-27 | 2007-04-27 | Usos medicos adicionales de la proteina antisecretora. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8487074B2 (enExample) |
| EP (1) | EP2037950B1 (enExample) |
| JP (2) | JP5508846B2 (enExample) |
| KR (1) | KR20090037992A (enExample) |
| AU (1) | AU2007244005B2 (enExample) |
| CA (1) | CA2650132C (enExample) |
| IL (1) | IL194775A (enExample) |
| MX (1) | MX2008013777A (enExample) |
| PL (1) | PL2037950T3 (enExample) |
| WO (1) | WO2007126365A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG171602A1 (en) * | 2006-04-27 | 2011-06-29 | Lantmaennen As Faktor Ab | Use of antisecretory factors for treating intraocular hypertension |
| KR20090037992A (ko) | 2006-04-27 | 2009-04-17 | 란트만넨 아스-팍토르 아베 | 항분비 단백질의 추가적 의학 용도 |
| PL2040734T3 (pl) | 2006-04-27 | 2012-04-30 | Lantmaennen As Faktor Ab | Białko przeciwwydzielnicze do zastosowania w leczeniu zespołu przedziału |
| US9962424B2 (en) | 2007-04-27 | 2018-05-08 | Lantmännen As-Faktor Ab | Use of antisecretory factors (AF) for optimizing cellular uptake |
| US8901083B2 (en) | 2008-11-25 | 2014-12-02 | Temple University | Administration of angiocidin for the treatment of leukemia |
| JP5820277B2 (ja) | 2009-02-11 | 2015-11-24 | ラントメネン・アーエス−ファクトール・アーベー | 細胞取込を最適化するための抗分泌性因子（ａｆ）の使用 |
| WO2017009004A1 (en) | 2015-07-10 | 2017-01-19 | Lantmännen As-Faktor Ab | Process for producing egg yolk with high content of af-16 |
| US11407796B2 (en) | 2016-07-18 | 2022-08-09 | Lantmännen As-Faktor Ab | Antisecretory factor 17 |
| WO2020002464A1 (en) | 2018-06-28 | 2020-01-02 | Lantmännen Medical Ab | Antisecretory factor for use in treatment and/or prevention of acute respiratory failure |
| WO2022159845A1 (en) * | 2021-01-22 | 2022-07-28 | University Of Virginia Patent Foudation | Altering protein function by pharmacological targeting of membrane domains |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585401A (en) | 1994-12-09 | 1996-12-17 | The Reents Of The University Of California | Method for enhancing outflow of aqueous humor in treatment of glaucoma |
| SE508609C2 (sv) | 1995-08-24 | 1998-10-19 | Rural Patent Svenska Ab | Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning |
| WO1997027296A1 (en) * | 1996-01-26 | 1997-07-31 | Hsc Research And Development Limited Partnership | Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| SE9604251L (sv) | 1996-11-20 | 1997-12-22 | Svenska Lantmaennen Riksfoerbu | Födoämne som vid förtäring inducerar antisekretoriska proteiner |
| SE513496C2 (sv) | 1998-12-17 | 2000-09-18 | Rural Patent Svenska Ab | NASP-berikad äggula samt dess användning |
| GB0322645D0 (en) * | 2003-09-26 | 2003-10-29 | Melacure Therapeutics Ab | Use of antisecretory factor peptides |
| KR20090037992A (ko) | 2006-04-27 | 2009-04-17 | 란트만넨 아스-팍토르 아베 | 항분비 단백질의 추가적 의학 용도 |
| PL2040734T3 (pl) * | 2006-04-27 | 2012-04-30 | Lantmaennen As Faktor Ab | Białko przeciwwydzielnicze do zastosowania w leczeniu zespołu przedziału |
| EP2682819A2 (en) * | 2012-07-04 | 2014-01-08 | Xeikon IP B.V. | A method for forming a multi-colour image |
-
2007
- 2007-04-27 KR KR1020087029121A patent/KR20090037992A/ko not_active Ceased
- 2007-04-27 WO PCT/SE2007/000415 patent/WO2007126365A2/en not_active Ceased
- 2007-04-27 MX MX2008013777A patent/MX2008013777A/es active IP Right Grant
- 2007-04-27 JP JP2009507637A patent/JP5508846B2/ja not_active Expired - Fee Related
- 2007-04-27 CA CA2650132A patent/CA2650132C/en not_active Expired - Fee Related
- 2007-04-27 EP EP07748080.4A patent/EP2037950B1/en not_active Not-in-force
- 2007-04-27 PL PL07748080T patent/PL2037950T3/pl unknown
- 2007-04-27 AU AU2007244005A patent/AU2007244005B2/en not_active Ceased
-
2008
- 2008-10-22 IL IL194775A patent/IL194775A/en active IP Right Grant
- 2008-10-27 US US12/289,390 patent/US8487074B2/en not_active Expired - Fee Related
-
2014
- 2014-01-28 JP JP2014013388A patent/JP6063401B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20090149382A1 (en) | 2009-06-11 |
| KR20090037992A (ko) | 2009-04-17 |
| WO2007126365A2 (en) | 2007-11-08 |
| EP2037950B1 (en) | 2014-04-23 |
| JP5508846B2 (ja) | 2014-06-04 |
| AU2007244005A1 (en) | 2007-11-08 |
| PL2037950T3 (pl) | 2014-09-30 |
| IL194775A0 (en) | 2011-08-01 |
| HK1128237A1 (en) | 2009-10-23 |
| WO2007126365A8 (en) | 2009-03-05 |
| JP2009535330A (ja) | 2009-10-01 |
| JP2014111623A (ja) | 2014-06-19 |
| EP2037950A2 (en) | 2009-03-25 |
| IL194775A (en) | 2015-09-24 |
| CA2650132C (en) | 2017-10-24 |
| US8487074B2 (en) | 2013-07-16 |
| WO2007126365A3 (en) | 2008-03-13 |
| JP6063401B2 (ja) | 2017-01-18 |
| AU2007244005B2 (en) | 2012-08-02 |
| CA2650132A1 (en) | 2007-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG171601A1 (en) | Further medical uses of antisecretory protein | |
| WO2007126365A3 (en) | Further medical uses of antisecretory protein | |
| WO2010126626A3 (en) | Dual mechanism inhibitors for the treatment of disease | |
| WO2008042688A3 (en) | Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 | |
| WO2008076754A3 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| WO2010123930A3 (en) | Chemosensory receptor ligand-based therapies | |
| WO2011041461A3 (en) | Polycyclic compounds as lysophosphatidic acid receptor antagonists | |
| WO2008080082A3 (en) | Methods for modulating set and uses thereof | |
| WO2011041694A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
| WO2011017350A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
| WO2009108720A3 (en) | Antagonists of prostaglandin d2 receptors | |
| WO2010141761A3 (en) | Polycyclic antagonists of lysophosphatidic acid receptors | |
| WO2010077882A3 (en) | Antagonists of lysophosphatidic acid receptors | |
| WO2006047516A3 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| WO2008076392A3 (en) | Compounds useful as protein kinase inhibitors | |
| WO2010003127A3 (en) | Antagonists of prostaglandin d2 receptors | |
| WO2012021629A3 (en) | Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease | |
| WO2007106181A3 (en) | Glucagon receptor antagonists, preparation and therapeutic uses | |
| WO2009050136A3 (en) | Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome | |
| WO2009145989A3 (en) | Aminoalkylphenyl antagonists of prostaglandin d2 receptors | |
| WO2010042652A3 (en) | Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors | |
| WO2008001195A3 (en) | Novel processes for the preparation of dpp iv inhibitors | |
| IL194883A0 (en) | Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and paracetamol | |
| WO2007120270A3 (en) | Glucagon receptor antagonists, preparation and therapeutic uses | |
| WO2007120284A3 (en) | Glucagon receptor antagonists, preparation and therapeutic uses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |